1-3 of 3
Yong Yang
Close
Sort by
Journal Articles

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Clinical Trials & Observations
Shu-Nan Qi, Yong Yang, Yu-Qin Song, Ying Wang, Xia He, Chen Hu, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Xue-Ying Qiao, Hua Wang, Gao-Feng Li, Hui-Qiang Huang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Li-Ming Xu, Zhi-Yong Yuan, Hang Su, Jun Zhu, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3141–3153.
https://doi.org/10.1182/bloodadvances.2020001852
Published: 2020
Includes: Supplemental data
Journal Articles

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Clinical Trials & Observations
Tao Wu, Yong Yang, Su-Yu Zhu, Mei Shi, Hang Su, Ying Wang, Xia He, Li-Ming Xu, Zhi-Yong Yuan, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Sheng-Min Lan, Jun-Xin Wu, Chen Hu, Shu-Nan Qi, Bo Chen, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2369–2377.
https://doi.org/10.1182/bloodadvances.2018021311
Published: 2018
Includes: Supplemental data
Journal Articles

Uptake of [ 18 F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma

Clinical Trials & Observations
Shunan Qi, May Y. Huang, Yong Yang, Heiko Schöder, Sewit Teckie, Ariela Noy, Karen Chau, Joachim Yahalom
Journal: Blood Advances
Blood Adv (2018) 2 (6): 649–655.
https://doi.org/10.1182/bloodadvances.2017013698
Published: 2018
Includes: Supplemental data